Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Jun 22;5(6):acmi000498.v3.
doi: 10.1099/acmi.0.000498.v3. eCollection 2023.

First report of a carbapenemase OXA-48-producing Hafnia alvei clinical isolate

Affiliations
Case Reports

First report of a carbapenemase OXA-48-producing Hafnia alvei clinical isolate

Laura Sevillano et al. Access Microbiol. .

Abstract

Introduction: Carbapenems are usually used in the treatment of infections caused by cephalosporin-resistant Enterobacterales ; however, the increase in carbapenem-resistant Enterobacterales (CRE) has become one of the most important problems in public health. Hafnia alvei is associated with intestinal and extraintestinal infections, especially in patients with any chronic disease or some type of immunosupression. H. alvei is resistant to first-generation aminopenicillins and cephalosporins owing to the β-lactamase (Amp C) in their chromosome; the only carbapenem-resistant Hafnia strain described until now was due to a lack of the OmpK36 protein that plays an important role in permeability to carbapenems.

Case presentation: We present the case of a 65-year-old male diagnosed with acute lithiasic cholecystitis. Culture of the biliary prosthesis yielded a OXA-48-producing H. alvei that was identified by MALDI-TOF (matrix-assisted laser desorption/ionization-time of flight) MS. Carbapenemase production was detected by immunochromatography and confirmed by sequencing.

Conclusion: To our knowledge, this is the first report of OXA-48-producing H. alvei probably obtained by horizontal transfer from Enterobacter cloacae OXA-48 isolated in previous samples.

Keywords: Hafnia alvei; OXA-48; carbapenem; carbapenemase.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Figures

Fig. 1.
Fig. 1.
Abdominal ultrasound: acute cholecystitis and intra- and extra-hepatic biliary dilatation.
Fig. 2.
Fig. 2.
Abdominal CT scan: multiple cholelithiasis with acute cholecystitis.

References

    1. Ruppé É, Woerther P-L, Barbier F. Mechanisms of antimicrobial resistance in Gram-negative bacilli . Ann Intensive Care. 2015;5:61. doi: 10.1186/s13613-015-0061-0. - DOI - PMC - PubMed
    1. Maurer FP, Castelberg C, Quiblier C, Bloemberg GV, Hombach M. Evaluation of carbapenemase screening and confirmation tests with Enterobacteriaceae and development of a practical diagnostic algorithm. J Clin Microbiol. 2015;53:95–104. doi: 10.1128/JCM.01692-14. - DOI - PMC - PubMed
    1. Katchanov J, Asar L, Klupp E-M, Both A, Rothe C, et al. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations. PLoS One. 2018;13:e0195757. doi: 10.1371/journal.pone.0195757. - DOI - PMC - PubMed
    1. Sánchez-López J, Cantón R. Current status of ESKAPE microorganisms in Spain: epidemiology and resistance phenotypes. Rev Esp Quimioter. 2019;32 Suppl 2:27–31. - PMC - PubMed
    1. Ramos-Vivas J. Microbiología de Hafnia alvei . Enferm Infecc Microbiol Clín. 2020;38:1–6. doi: 10.1016/j.eimc.2020.02.001. - DOI - PubMed

Publication types

LinkOut - more resources